TR
The Readout
101 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
51
Activity (Last 30 Days)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2026-03-232026-04-17
Top Publishers
Stat News51 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: A new trick for old science, and biotech VCs’ scrambled playbook
Stat News|4/10/2026
UNVERIFIEDSingle Source
STAT+: Terns’ drug may not be as competitive as many initially thought
Stat News|4/8/2026
UNVERIFIEDSingle Source
STAT+: Biotech investors’ plea to Trump, and a busy M&A week
Stat News|4/3/2026
UNVERIFIEDSingle Source
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Stat News|4/2/2026
UNVERIFIEDSingle Source
STAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups
Stat News|4/1/2026
UNVERIFIEDSingle Source
STAT+: Psychedelic biotechs face scrutiny over YouTube promos
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Biogen lupus drug improves skin clearance in mid-stage study
Stat News|3/30/2026
UNVERIFIEDSingle Source
STAT+: Denali Therapeutics, Corcept Therapeutics win FDA approvals
Stat News|3/26/2026
UNVERIFIEDSingle Source
STAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Pfizer’s Lyme vaccine results set up tricky regulatory path
Stat News|3/23/2026
UNVERIFIEDSingle Source
STAT+: Medicare chief says TrumpRx is meant to be narrow in scope
Stat News|3/20/2026
UNVERIFIEDSingle Source
STAT+: Eli Lilly’s ‘triple-G’ shows potency, raises concerns
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Senator blasts GSK inhaler practices, calls for reform
Stat News|3/17/2026
UNVERIFIEDSingle Source
STAT+: FDA launches unified system for adverse event reports
Stat News|3/12/2026
UNVERIFIEDSingle Source
STAT+: FDA approves leucovorin for rare disorder without trial data
Stat News|3/11/2026
UNVERIFIEDSingle Source
STAT+: FDA warns more telehealth firms about compounded GLP-1s
Stat News|3/4/2026
UNVERIFIEDSingle Source
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: FDA rejection is a reality check on agency rhetoric
Stat News|2/26/2026
UNVERIFIEDSingle Source
STAT+: Novo’s next-gen obesity drug stumbles in Lilly comparison study
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: Element Biosciences launches table-top sequencer capable of $100 genome
Stat News|2/20/2026
UNVERIFIEDSingle Source
STAT+: The unusual Prasad missive in the FDA’s rejection of the Moderna flu shot application
Stat News|2/11/2026
UNVERIFIEDSingle Source
STAT+: Evommune reports positive mid-stage data for eczema drug
Stat News|2/10/2026
UNVERIFIEDSingle Source
STAT+: Novo and Lilly both see price cuts as helpful for long-term gain
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Launch of Wegovy pill looks to be going strong so far
Stat News|1/26/2026